Asia Biomaterials invites you to meet us at COA 2026

From November 11-15, the International Business Unit at Asia Biomaterials will attend the COA 2026 in Guangzhou, China, meet our team at booth: 18.2-S16

From November 11-15, the COA2026 (the 18th Annual Congress of the Chinese Orthopaedic Association), one of the largest congresses for Orthopeadic, will be held in Guangzhou China.

Building on the successful launches at COA2025 and COA2024, we return this year with an expanded portfolio. Discover our three revolutionary products designed to advance surgical reconstruction:
DeepActive™ Synthetic Bone Graft: A Silicon-doped, high-activity synthetic bone graft free of growth factors, with a hierarchical biomimetic micro-nano structure to facilitate osseointegration and bone regeneration. China NMPA registration data: 100% bone graft fusion rate at 24 weeks after implantation.
DeepActive™ Dermal Regeneration Matrix: A major strategic product under China's National Key R&D Program, designed for dry-state preservation and ambient-temperature transport, representing a breakthrough in wound care and surgical reconstruction.
DeepActive Anti-Tumor™ Synthetic Bone Graft: The world's first selenium-doped, high-activity synthetic bone graft with a hierarchical biomimetic micro-nano structure, boosting osteogenic activity by over 50% and achieving a bone tumor inhibition rate exceeding 67%.

We sincerely look forward to meeting you at our booth and exploring how we can work together to advance patient care.